In addition, the binding of CypD and Bcl-2 enhances the limiting effect of Bcl-2 on cytochrome C (Cyto C) release and improves the antiapoptotic effect of various tumor cell lines (human osteosarcoma cell line Saos2 and human acute leukemia cell line HL60) (55). Here, BCL2 is linked to neoplasm.